Lipid Nutrition global group manager in marketing, John Kurstjens, is “a little bit disappointed” about the recent EFSA health claim opinion on CLA which included a range of claim dismissals but remained strangely silent about the claim that matters most to CLA players – body fat reduction.
CLA specialist Lipid Nutrition will submit a tightly focused ‘body fat reduction’ health claim submission to the EU process after the European Food Safety Authority last week canned a host of generic, article 13.1 claims for the fatty acid.
German supplier Cognis improved EBITDA performance by 67.5 per cent in the first half of 2010- but its nutrition and health division lagged behind the performance of its household chemicals and personal care divisions.
In the second part of our special series on eye health, NutraIngredients takes a closer look at the science behind lutein, omega-3 and the other ingredients eyeing a place on the podium for eye health.
BASF’s €3.1bn buy-out of Cognis is driven by interest in all of the German company’s three divisions – personal care, household chemical and human nutrition – but although human nutrition is the smallest part of the acquired operation, it was vital to the deal’s success.
German chemicals and nutrients giant Cognis has turned in its best ever Q1 operating profit as sales across its three core divisions exceeded 2008 pre-financial crisis volumes in 2008 for the first time - fueling ongoing buy-out speculation.
Fat reduction ingredient conjugated linoleic acid (CLA) is one step closer to novel food approval in Europe, after the European Food Safety Authority (EFSA) gave its stamp of approval for the ingredient’s safety.